ERBB2 and breast carcinoma: BG modification of MMAF has been shown to effectively induce apoptosis at nanomolar concentrations in breast cancer and human solid tumor cells when conjugated to recombinant scFv fragments targeting HER2 and EGFR (Woitok et al. 2016, 2017; Huysamen et al. 2023).